Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Open-Labeled Study of 0.05% Difluprednate Ophthalmic Emulsion in the Treatment of Severe Anterior Uveitis (Including Panuveitis).

NCT00407056 is registered in ClinicalTrials.gov with Sirion Therapeutics, Inc. as lead sponsor.

NCT NCT00407056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00407056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Open-Labeled Study of 0.05% Difluprednate Ophthalmic Emulsion in the Treatment of Severe Anterior Uveitis (Including Panuveitis).
Lead sponsor
Sirion Therapeutics, Inc.
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2002
Completion date
June 30, 2003
Enrollment
20
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

panuveitis, uveitis